ArticleTropical medicine and health2026
From clinical fluids to environmental matrices: quantitative monitoring of infectious monkeypox virus based on PMA-qPCR during the Guangdong outbreak.
Article in Tropical medicine and health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
backgroundMpox, caused by monkeypox virus (MPXV), remains a public health priority. Standard qPCR detects viral DNA but cannot distinguish infectious virions from residual genetic material of inactivated virus, complicating transmission risk assessment. This study aimed to develop a rapid assay for quantifying infectious MPXV across clinical and environmental matrices in Guangdong Province, China.
methodsWe developed a propidium monoazide-assisted qPCR (PMA-qPCR) assay that selectively amplifies DNA from intact virions, and embedded it within the Guangdong provincial Center for Disease Control and Prevention surveillance network. We examined 23 clinical fluid specimens from 15 mpox patients, 337 surface swabs and 53 domestic wastewater samples from patient living environments, and 498 terminal wastewater samples from flights and sewage treatment plants collected between June 2023 and August 2024. Decay kinetics were evaluated at 25 °C and 30 °C under varying pH, with initial viral loads of 10
resultsPMA-qPCR discriminated infectious from non-infectious virus. Co-incubation with 50 μM PMA and 0.005% SDS effectively blocked amplification of non-infectious DNA, and the assay showed quantitative concordance with the standard plaque assay. Infectious MPXV loads were highest in skin lesions and anal swabs, exceeding throat swabs by more than 100-fold. Among surface samples, 41.54% (140/337) tested positive for MPXV DNA by qPCR, but only 25.71% (36/140) of these contained infectious virus at low loads (126.79 ± 93.57 PFU/mL). For wastewater, 11.32% (6/53) of domestic samples from patient living environments tested positive by qPCR, yet no infectious MPXV was detected. No MPXV DNA was detected in 498 terminal wastewater samples from flights or sewage treatment plants. Decay experiments demonstrated that when the initial concentration was 10
conclusionsPMA-qPCR provides a practical tool for rapid cross-matrix quantification of infectious MPXV. Direct contact with skin lesions or anal secretions likely dominates transmission, whereas environmental persistence is limited. Testing for infectious virus within 48 h of collection is recommended, as infectious MPXV decays by over 99% within this window.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.